Atlas Trials

Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia

Clinical trial NCT00626392 · COMPLETED

Trial details

NCT number
NCT00626392
Sponsor
Abbott
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2008-02-01
Primary completion
2008-04-01
Enrollment
277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.